MedTrace Logo

Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients

NCT05417152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2023-06-15

No results posted yet for this study

Summary

In this clinical study the Notal Vision Home OCT (NVHO) Monitoring System will be used to evaluate the ability of patients diagnosed with DME to perform sequential self-images of their eyes with the self-operated NVHO device in a home simulated environment in the doctor's office.

The study population will include up to 30 patients, with DR in at least one eye at the time of enrollment. All subjects will be enrolled at one site in Israel.

Conditions

Sponsors & Collaborators

  • Notal Vision Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-29
Primary Completion
2022-11-30
Completion
2023-03-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05417152 on ClinicalTrials.gov